Expression of oral secretory leukocyte protease inhibitor in HIV‐infected subjects with long‐term use of antiretroviral therapy

Abstract

The expression of oral SLPI is altered by HIV infection and use of ART. Thus, oral SLPI may be the useful biomarker to identify subjects at risk of infections and malignant transformation due to HIV infection and long-term ART.